Form 4: Director Kapila Anand Increases Elanco Equity Stake
Director Compensation Disclosure
Director Kapila K. Anand acquired 600.7104 deferred stock units in Elanco Animal Health through a director fee deferral plan.
Summary
- Director Kapila K. Anand elected to defer cash retainer fees into the Elanco Directors' Deferral Plan.
- The transaction resulted in the acquisition of 600.7104 Deferred Stock Units (DSUs).
- The units were granted at a price of $23.93 per share based on the closing price on March 31, 2026.
- Following this transaction, the director holds a total of 9,495.4518 units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing reflecting standard director compensation practices.
Positives
- Demonstrates alignment of interest between the director and shareholders through equity-based compensation.
- Reflects confidence in the company's long-term value by opting for stock units over cash.
Negatives
- None identified; this is a routine administrative transaction related to director compensation.
Risks
- Value of the deferred stock units is subject to the market performance of Elanco common stock.
Future Outlook
The deferred stock units will be settled in common stock upon the director's separation of service from the Board of Directors.
Management Comments
- The director elected to defer cash retainer fees pursuant to the Company's Directors' Deferral Plan.
Industry Context
StockSavvy.ai notes that director fee deferral programs are standard corporate governance practices designed to ensure board members maintain a meaningful equity stake in the company they oversee.
Comparison to Industry Standards
- The use of deferred stock units for director compensation is consistent with standard practices among large-cap pharmaceutical and animal health companies.
- Alignment with peers such as Zoetis or Merck in utilizing equity-based retention for board members.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Director elected to defer cash fees into stock units. | 03/31/2026 | Increases director's equity alignment with shareholders. |
Stakeholder Impact
- Shareholders benefit from increased director equity alignment.
Next Steps
- Settlement of units into common stock upon the director's future departure from the Board.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of the transaction and grant of deferred stock units. |
| 04/02/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Elanco, ELAN, Director, Insider Trading, Form 4, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.